Antiretroviral therapy requires life-long adherence

The Lancet Infectious Diseases

Volumn 12, Issue 9, 2012, Pages 661-662

  De Pee, Saskia ^a   Grede, Nils ^a   Forsythe, Maureen ^a   Bloem, Martin W ^a  

^a World Food Programme   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; ANTIRETROVIRUS AGENT;

AFRICA; CLINICAL EVALUATION; HEALTH CARE PLANNING; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; LETTER; LONG TERM CARE; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PREVALENCE; PRIORITY JOURNAL;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; HIV INFECTIONS; HUMANS; MEDICATION ADHERENCE;

EID: 84865293652     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(12)70170-6     Document Type: Letter

References (4)

1. Bärnighausen T, Chaiyachati K, Chimbindi N, Peoples A, Haberer J, Newell M-L Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis 2011, 11:942-951.
2. Rosen S, Fox MP, Gill CJ Patient retention in antiretroviral therapy prorams in Sub-Saharan Africa: a systematic review. PLoS Med 2007, 4:1691-1701.
3. Unge C, Södergård B, Marrone G, et al. Long-term adherence to antiretroviral treatment and program drop-out in a high-risk urban setting in sub-Saharan Africa: a prospective cohort study. PLoS Med 2010, 5:1-12.
4. Habicht JP, Victora CG, Vaughan JP Evaluation designs for adequacy, plausibility and probability of public health programme performance and impact. Int J Epidemiol 1999, 28:10-18.